GRN (Progranulin) variants and mutations
GRN (also known as Progranulin) is a human protein-coding gene encoding a progranulin protein. It is secreted and proteolytically processed into granulins and has roles in lysosomal function, inflammation, neuronal survival, and tissue repair. Heterozygous loss-of-function variants cause frontotemporal dementia through progranulin haploinsufficiency, while biallelic loss causes neuronal ceroid lipofuscinosis. This analysis covers 1,037 GRN variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, and CLN11 disease. Example GRN variants include M1I, M1T, and M1V.
Variant analysis overview
- Gene: GRN
- Protein: Progranulin
- UniProt accession: P28799
- Organism: Homo sapiens
- Variants analyzed: 1037
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 794 unspecified-consequence records; 98 missense variants; 105 synonymous variants; 16 frameshift variants; 1 protein altering variant; 7 splice-region variants; 4 stop-gained variants; 1 in-frame deletions; 1 in-frame insertions; 10 substitution
- Prediction scores: 810 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, CLN11 disease, frontotemporal dementia, adult neuronal ceroid lipofuscinosis, Alzheimer disease, dementia, hereditary disease, amyotrophic lateral sclerosis, neuronal ceroid lipofuscinosis, infantile neuronal ceroid lipofuscinosis, primary progressive aphasia.
Protein structure and variant hotspots
- Protein features: 5 post-translational modification sites.
- PTM context: 10 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable GRN variants
Examples include M1I, M1T, M1V, W2*, T3A, T3I, T3S, T3N. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs63750331, ClinGen CA225196, ClinVar RCV000017382, ClinVar RCV000084420, MetaLR 0.56, MetaSVM 0.36, Pathogenic, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
- M1T (p.Met1Thr), rs63751006, ClinGen CA225193, ClinVar RCV000017381, ClinVar RCV000084419, MetaLR 0.55, MetaSVM 0.36, Pathogenic, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- M1V (p.Met1Val), rs746037872, ClinGen CA399758963, ClinVar RCV002047593, MetaLR 0.55, MetaSVM 0.16, Pathogenic, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- W2* (p.Trp2Ter), rs2510054161, ClinGen CA399758978, ClinVar RCV003789585, Pathogenic
- T3A (p.Thr3Ala), rs2048347394, ClinGen CA399758989, ClinVar RCV001197111, ClinVar RCV005348348, AlphaMissense 0.08, MetaLR 0.15, Uncertain significance, Inborn genetic diseases; Neuronal ceroid lipofuscinosis 11
- T3I (p.Thr3Ile), rs375939802, ClinGen CA8601728, ClinVar RCV003284827, ClinVar RCV003779907, REVEL 0.09, AlphaMissense 0.12, Uncertain significance, Inborn genetic diseases; Neuronal ceroid lipofuscinosis 11; GRN-related frontote
- T3S (p.Thr3Ser), rs375939802, ClinGen CA290922147, ClinVar RCV000811134, ESP rs375939802, AlphaMissense 0.12, MetaLR 0.18, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- T3N (p.Thr3Asn), gnomAD 17-44349172-C-A, REVEL 0.20, CADD 15.70
- T3T (p.Thr3Thr), gnomAD 17-44349173-C-T, CADD 5.36
- V5L (p.Val5Leu), Ensembl rs1555610859
- V5M (p.Val5Met), Ensembl rs1555610859, REVEL 0.23, CADD 23.50
- V5V (p.Val5Val), rs762647010, gnomAD 17-44349179-G-C, CADD 10.30
- S6G (p.Ser6Gly), TOPMed rs2048347508
- S6R (p.Ser6Arg), rs768654819, ClinGen CA399759026, ClinVar RCV002710760, ExAC rs768654819, AlphaMissense 0.77, MetaLR 0.46, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- S6S (p.Ser6Ser), rs768654819, gnomAD 17-44349182-C-T, AlphaMissense 0.77, MetaLR 0.46
- W7* (p.Trp7Ter), cosmic curated COSV10437, TOPMed rs2048347591
- W7G (p.Trp7Gly), rs1555610861, ClinGen CA399759034, ClinVar RCV003022829, REVEL 0.60, CADD 27.90, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- W7R (p.Trp7Arg), Ensembl rs1555610861
- W7S (p.Trp7Ser), gnomAD 17-44349184-G-C, REVEL 0.66, CADD 25.30
- V8A (p.Val8Ala), TOPMed rs2048347640
- V8M (p.Val8Met), rs774367010, ClinGen CA8601731, ClinVar RCV000729976, ClinVar RCV002477697, REVEL 0.17, CADD 21.10, Uncertain significance, not provided; GRN-related frontotemporal lobar degeneration with Tdp43 inclusion
- V8E (p.Val8Glu), gnomAD 17-44349187-T-A, REVEL 0.51, CADD 23.10
- V8V (p.Val8Val), rs1318632635, gnomAD 17-44349188-G-A, CADD 8.74
- A9D (p.Ala9Asp), rs63751243, ClinGen CA225199, ClinVar RCV000017386, ClinVar RCV000084421, AlphaMissense 0.10, MetaLR 0.41, Pathogenic, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- A9T (p.Ala9Thr), TOPMed rs1180124944, gnomAD rs1180124944, REVEL 0.07, CADD 17.80, Uncertain significance, Inborn genetic diseases
- A9V (p.Ala9Val), rs63751243, ClinGen CA8601732, ClinVar RCV002958641, ExAC rs63751243, REVEL 0.33, AlphaMissense 0.10, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- L10F (p.Leu10Phe), rs1256353751, ClinGen CA399759073, ClinVar RCV003033498, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- L10L (p.Leu10Leu), rs1256353751, gnomAD 17-44349194-A-G, CADD 0.29
- T11S (p.Thr11Ser), gnomAD 17-44349195-A-T, REVEL 0.09, CADD 6.69
- T11A (p.Thr11Ala), gnomAD 17-44349195-A-G, REVEL 0.03, CADD 7.91
- A12T (p.Ala12Thr), Ensembl rs2048347801, REVEL 0.04, CADD 16.50
- G13A (p.Gly13Ala), rs1457930333, ClinGen CA399759105, ClinVar RCV001330880, TOPMed rs1457930333, REVEL 0.26, CADD 22.90, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
- G13E (p.Gly13Glu), TOPMed rs1457930333, gnomAD rs1457930333, Uncertain significance
- G13R (p.Gly13Arg), ExAC rs767088439, gnomAD rs767088439, REVEL 0.47, CADD 21.50
- L14P (p.Leu14Pro), TOPMed rs2048347855
- L14L (p.Leu14Leu), gnomAD 17-44349204-C-T, CADD 9.76
- V15L (p.Val15Leu), TOPMed rs1209593564, gnomAD rs1209593564, REVEL 0.30, CADD 25.00
- V15M (p.Val15Met), gnomAD 17-44349207-G-A, REVEL 0.34, CADD 25.70
- V15V (p.Val15Val), rs760445997, gnomAD 17-44349209-G-A, CADD 7.29
- A16S (p.Ala16Ser), gnomAD rs1482233397, REVEL 0.19, CADD 15.90
- A16T (p.Ala16Thr), gnomAD rs1482233397, REVEL 0.24, CADD 17.30
- A16V (p.Ala16Val), rs2048348002, ClinGen CA399759140, ClinVar RCV003063520, TOPMed rs2048348002, REVEL 0.10, CADD 20.70, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- G17A (p.Gly17Ala), rs2048348029, ClinGen CA399759151, ClinVar RCV002944274, AlphaMissense 0.23, MetaLR 0.48, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- G17E (p.Gly17Glu), gnomAD rs2048348029, REVEL 0.49, AlphaMissense 0.23
- T18A (p.Thr18Ala), rs1003823098, ClinGen CA290922172, ClinVar RCV002251715, Ensembl rs1003823098, REVEL 0.19, CADD 18.80, Pathogenic, Parkinsonian disorder
- T18M (p.Thr18Met), rs199572314, ClinGen CA8601736, ClinVar RCV000521954, ClinVar RCV000764130, REVEL 0.32, CADD 18.00, Uncertain significance, Inborn genetic diseases; Neuronal ceroid lipofuscinosis 11; GRN-related frontote
- T18T (p.Thr18Thr), rs753160641, gnomAD 17-44349218-G-A, CADD 1.11
- R19Q (p.Arg19Gln), rs764665710, ClinGen CA8601738, cosmic curated COSV50007, ClinVar RCV001952401, REVEL 0.03, CADD 5.02, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- R19W (p.Arg19Trp), rs63750723, ClinGen CA225201, cosmic curated COSV99029, ClinVar RCV000084422, REVEL 0.14, CADD 13.60, Benign, Inborn genetic diseases; GRN-related frontotemporal lobar degeneration with Tdp4
- R19L (p.Arg19Leu), gnomAD 17-44349220-G-T, REVEL 0.10, CADD 9.97
- R19R (p.Arg19Arg), rs1426790644, gnomAD 17-44349221-G-T, CADD 8.31
- C20G (p.Cys20Gly), 1000Genomes rs542613543, ExAC rs542613543, TOPMed rs542613543, gnomAD rs542613543, REVEL 0.79, CADD 25.00, Uncertain significance
- C20R (p.Cys20Arg), rs542613543, ClinGen CA8601739, ClinVar RCV001318543, ClinVar RCV004978315, REVEL 0.80, CADD 24.80, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- C20Y (p.Cys20Tyr), ExAC rs757346713, TOPMed rs757346713, gnomAD rs757346713, REVEL 0.78, CADD 24.80
- C20C (p.Cys20Cys), gnomAD 17-44349224-C-T, CADD 7.94
- P21A (p.Pro21Ala), ExAC rs781295861, gnomAD rs781295861, REVEL 0.60, CADD 23.60
- P21L (p.Pro21Leu), rs745947095, ClinGen CA8601742, ClinVar RCV001912397, ExAC rs745947095, REVEL 0.72, CADD 24.60, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- P21S (p.Pro21Ser), ExAC rs781295861, gnomAD rs781295861, REVEL 0.64, CADD 24.30
- D22E (p.Asp22Glu), gnomAD rs2048348383, REVEL 0.37, CADD 24.10
- D22G (p.Asp22Gly), TOPMed rs1300536059, gnomAD rs1300536059, REVEL 0.59, CADD 24.40
- D22Y (p.Asp22Tyr), gnomAD 17-44349228-G-T, REVEL 0.56, CADD 25.90
- D22D (p.Asp22Asp), gnomAD 17-44349230-T-C, CADD 12.00
- G23D (p.Gly23Asp), rs1322702054, TOPMed rs1322702054, AlphaMissense 0.17, MetaLR 0.43, Variant assessed as somatic; moderate impact.
- G23R (p.Gly23Arg), gnomAD 17-44349231-G-C, REVEL 0.62, CADD 25.90
- G23S (p.Gly23Ser), gnomAD 17-44349231-G-A, REVEL 0.63, CADD 26.50
- G23G (p.Gly23Gly), rs756420341, gnomAD 17-44349233-T-C, CADD 9.02
- Q24* (p.Gln24Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q24H (p.Gln24His), gnomAD rs1399446930, REVEL 0.39, CADD 23.40
- Q24R (p.Gln24Arg), gnomAD 17-44349235-A-G, REVEL 0.37, CADD 17.80
- F25L (p.Phe25Leu), gnomAD 17-44349237-T-C, REVEL 0.04, CADD 1.90
- C26* (p.Cys26Ter), rs2143325486, ClinGen CA399759260, ClinVar RCV001543435, Ensembl rs2143325486, Pathogenic
- C26F (p.Cys26Phe), cosmic curated COSV50007, ExAC rs780086363, TOPMed rs780086363, gnomAD rs780086363, REVEL 0.72, CADD 25.10
- C26Y (p.Cys26Tyr), ExAC rs780086363, TOPMed rs780086363, gnomAD rs780086363, REVEL 0.69, CADD 25.10
- C26G (p.Cys26Gly), gnomAD 17-44349240-T-G, REVEL 0.69, CADD 25.20
- P27L (p.Pro27Leu), TOPMed rs2048348537, REVEL 0.46, CADD 24.10
- P27S (p.Pro27Ser), gnomAD 17-44349243-C-T, REVEL 0.32, CADD 20.40
- P27P (p.Pro27Pro), rs749117254, gnomAD 17-44349245-T-C, CADD 4.46
- V28M (p.Val28Met), gnomAD rs1220101588
- V28C (p.Val28Cys), rs1392550887, gnomAD 17-44349241-G-GC, CADD 25.80
- V28V (p.Val28Val), gnomAD 17-44349248-G-A, CADD 10.80
- A29S (p.Ala29Ser), NCI-TCGA Cosmic COSV5000, cosmic curated COSV50006, Variant assessed as somatic; moderate impact.
- A29V (p.Ala29Val), rs1567885405, ClinGen CA399759297, ClinVar RCV002611797, TOPMed rs1567885405, REVEL 0.44, CADD 19.50, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- A29T (p.Ala29Thr), gnomAD 17-44349249-G-A, REVEL 0.36, CADD 21.90
- A29D (p.Ala29Asp), gnomAD 17-44349250-C-A, REVEL 0.51, CADD 22.90
- A29A (p.Ala29Ala), rs1294053742, gnomAD 17-44349251-C-A, CADD 13.20
- C30L (p.Cys30Leu), rs794729672, gnomAD 17-44349249-G-GC, CADD 27.10
- C30Y (p.Cys30Tyr), gnomAD 17-44349253-G-A, REVEL 0.61, CADD 26.10
- C30C (p.Cys30Cys), gnomAD 17-44349254-C-T, CADD 13.00
- C31L (p.Cys31Leu), rs63751057, gnomAD 17-44349248-G-GGC, CADD 26.60
- C31C (p.Cys31Cys), gnomAD 17-44349257-C-T, CADD 10.70
- L32L (p.Leu32Leu), gnomAD 17-44349258-C-T, CADD 9.71
- L32P (p.Leu32Pro), gnomAD 17-44349259-T-C, REVEL 0.24, CADD 18.60
- D33A (p.Asp33Ala), Ensembl rs1598362594
- D33E (p.Asp33Glu), rs63750742, ClinGen CA8601746, ClinVar RCV001124955, ClinVar RCV001242925, REVEL 0.11, CADD 8.00, Conflicting interpretations, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- D33N (p.Asp33Asn), Ensembl rs1021941321, REVEL 0.09, CADD 21.00
- D33V (p.Asp33Val), gnomAD 17-44349262-A-T, REVEL 0.41, CADD 22.70
- D33G (p.Asp33Gly), gnomAD 17-44349262-A-G, REVEL 0.15, CADD 19.90
- D33D (p.Asp33Asp), rs63750742, gnomAD 17-44349263-C-T, CADD 6.66
- P34A (p.Pro34Ala), rs748147151, ClinGen CA10649397, ClinVar RCV000315887, ClinVar RCV003168477, AlphaMissense 0.08, MetaLR 0.24, Uncertain significance, Inborn genetic diseases; GRN-related frontotemporal lobar degeneration with Tdp4
- P34H (p.Pro34His), rs977833315, ClinGen CA399759352, ClinVar RCV003795153, REVEL 0.23, CADD 12.10, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- P34L (p.Pro34Leu), rs977833315, ClinGen CA290922260, ClinVar RCV002369315, ClinVar RCV005227659, REVEL 0.12, CADD 12.90, Uncertain significance, Inborn genetic diseases; GRN-related frontotemporal lobar degeneration with Tdp4
- P34S (p.Pro34Ser), rs748147151, ClinGen CA8601747, ClinVar RCV001360798, ExAC rs748147151, REVEL 0.07, AlphaMissense 0.08, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- P34T (p.Pro34Thr), ExAC rs748147151, TOPMed rs748147151, gnomAD rs748147151, REVEL 0.19, AlphaMissense 0.08, Uncertain significance
- P34R (p.Pro34Arg), gnomAD 17-44349265-C-G, REVEL 0.28, CADD 16.60
- P34P (p.Pro34Pro), rs63751074, gnomAD 17-44349266-C-T, CADD 0.33
- G35E (p.Gly35Glu), NCI-TCGA Cosmic COSV5000, cosmic curated COSV50006, Variant assessed as somatic; moderate impact.
- G35R (p.Gly35Arg), rs533451404, ClinGen CA8601748, NCI-TCGA Cosmic COSV5000, cosmic curated COSV50006, REVEL 0.22, CADD 24.70, Conflicting interpretations, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- G35G (p.Gly35Gly), gnomAD 17-44349269-A-G, CADD 14.20
- G36G (p.Gly36Gly), rs1190848176, gnomAD 17-44349272-A-G, CADD 15.10
- A37D (p.Ala37Asp), gnomAD rs1248005591, Uncertain significance
- A37T (p.Ala37Thr), gnomAD rs2048348973, REVEL 0.08, CADD 15.70
- A37V (p.Ala37Val), rs1248005591, ClinGen CA399759385, ClinVar RCV002028798, gnomAD rs1248005591, REVEL 0.11, CADD 13.20, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- A37G (p.Ala37Gly), gnomAD 17-44349274-C-G, REVEL 0.12, CADD 13.10
- A37A (p.Ala37Ala), gnomAD 17-44349275-C-T, CADD 9.76
- S38T (p.Ser38Thr), Ensembl rs2048349023
- S38G (p.Ser38Gly), gnomAD 17-44349276-A-G, REVEL 0.07, CADD 7.32
- Y39F (p.Tyr39Phe), TOPMed rs2048349047, gnomAD rs2048349047, REVEL 0.55, CADD 24.00, Uncertain significance, not provided; Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal loba
- Y39C (p.Tyr39Cys), gnomAD 17-44349280-A-G, REVEL 0.67, CADD 25.00
- Y39Y (p.Tyr39Tyr), gnomAD 17-44349281-C-T, CADD 8.69
- p.Ser40delinsArgCys, rs1478146759, gnomAD 17-44349282-A-AGA, CADD 31.00
- C41* (p.Cys41Ter), rs2510054302, ClinGen CA2580093866, ClinVar RCV002876284, Pathogenic
- C41S (p.Cys41Ser), gnomAD rs1190219145, REVEL 0.61, CADD 26.40
- C41Y (p.Cys41Tyr), ExAC rs760088921, gnomAD rs760088921, REVEL 0.58, CADD 27.00
- C41R (p.Cys41Arg), gnomAD 17-44349285-T-C, REVEL 0.75, CADD 27.80
- C41C (p.Cys41Cys), rs1452920555, gnomAD 17-44349287-C-T, CADD 12.40
- C42G (p.Cys42Gly), rs1160868911, ClinGen CA399759447, ClinVar RCV003991678, AlphaMissense 0.70, MetaLR 0.49, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
- C42R (p.Cys42Arg), gnomAD rs1160868911, REVEL 0.82, AlphaMissense 0.70
- C42Y (p.Cys42Tyr), TOPMed rs1361710653, gnomAD rs1361710653, REVEL 0.62, CADD 28.00
- C42C (p.Cys42Cys), rs2048349215, gnomAD 17-44349290-C-T, CADD 9.07
- R43C (p.Arg43Cys), NCI-TCGA Cosmic COSV5000, cosmic curated COSV50007, REVEL 0.13, CADD 21.00, Variant assessed as somatic; moderate impact.
- R43G (p.Arg43Gly), gnomAD rs1419686334, REVEL 0.07, CADD 14.80
- R43H (p.Arg43His), rs766068311, ClinGen CA8601750, cosmic curated COSV50007, ClinVar RCV002021401, REVEL 0.06, CADD 12.60, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- R43L (p.Arg43Leu), gnomAD 17-44349292-G-T, REVEL 0.15, CADD 7.33
- R43R (p.Arg43Arg), rs2143325907, gnomAD 17-44349293-T-C, CADD 6.64
- P44S (p.Pro44Ser), gnomAD 17-44349292-G-GT, CADD 16.80
- P44L (p.Pro44Leu), gnomAD 17-44349295-C-T, REVEL 0.26, CADD 22.70
- P44H (p.Pro44His), gnomAD 17-44349295-C-A, REVEL 0.21, CADD 18.30
- P44P (p.Pro44Pro), gnomAD 17-44349296-C-T, CADD 2.87
- L45V (p.Leu45Val), gnomAD 17-44349297-C-G, REVEL 0.07, CADD 0.09
- L46L (p.Leu46Leu), rs1351623830, gnomAD 17-44349302-G-A, CADD 20.80
- D47G (p.Asp47Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D47N (p.Asp47Asn), rs1239690384, ClinGen CA399759549, ClinVar RCV000689976, gnomAD rs1239690384, REVEL 0.21, CADD 25.80, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- D47V (p.Asp47Val), 1000Genomes rs200782457, ExAC rs200782457, gnomAD rs200782457, REVEL 0.33, CADD 23.00
- D47D (p.Asp47Asp), rs1162722716, gnomAD 17-44349428-C-T, CADD 10.80
- K48R (p.Lys48Arg), rs775685740, gnomAD 17-44349629-A-G, CADD 1.91
- K48T (p.Lys48Thr), gnomAD 17-44349629-A-C, CADD 1.90
- W49* (p.Trp49Ter), rs1598362746, ClinGen CA399759583, ClinVar RCV000995778, Ensembl rs1598362746, Pathogenic
- W49C (p.Trp49Cys), rs1277918638, ClinGen CA399759589, ClinVar RCV003803383, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- P50L (p.Pro50Leu), rs755224109, ClinGen CA8601778, ClinVar RCV003784434, ExAC rs755224109, REVEL 0.29, CADD 23.00, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- P50P (p.Pro50Pro), rs911519164, gnomAD 17-44349437-C-T, CADD 8.42
- T52A (p.Thr52Ala), gnomAD rs1467250180, REVEL 0.03, CADD 1.30
- L53P (p.Leu53Pro), rs63750481, ClinGen CA225215, ClinVar RCV000084430, Ensembl rs63750481, REVEL 0.24, CADD 20.70, not provided
- L53V (p.Leu53Val), rs906652114, ClinGen CA290922409, ClinVar RCV001766575, ClinVar RCV001862033, REVEL 0.10, CADD 7.51, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- L53L (p.Leu53Leu), gnomAD 17-44349446-G-A, CADD 12.70
- S54G (p.Ser54Gly), rs2143326730, ClinGen CA399759637, ClinVar RCV001910389, Ensembl rs2143326730, REVEL 0.18, CADD 25.70, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- R55T (p.Arg55Thr), TOPMed rs2048350633, REVEL 0.16, CADD 10.50
- R55W (p.Arg55Trp), rs1555610922, UniProt VAR 064626, Ensembl rs1555610922, REVEL 0.38, CADD 19.00
- R55R (p.Arg55Arg), gnomAD 17-44349452-G-A, CADD 8.96
- H56H (p.His56His), gnomAD 17-44349455-T-C, CADD 4.61
- L57M (p.Leu57Met), TOPMed rs2048350659
- L57R (p.Leu57Arg), rs545762769, ClinGen CA8601779, ClinVar RCV001041583, 1000Genomes rs545762769, REVEL 0.44, CADD 24.70, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- L57L (p.Leu57Leu), rs752552167, gnomAD 17-44349458-G-C, CADD 6.09
- G58S (p.Gly58Ser), ExAC rs758199939, TOPMed rs758199939, gnomAD rs758199939, REVEL 0.14, CADD 16.80
- G58G (p.Gly58Gly), rs1338099002, gnomAD 17-44349461-T-G, CADD 2.51
- G59A (p.Gly59Ala), rs1456999060, ClinGen CA399759701, ClinVar RCV003798290, REVEL 0.07, CADD 0.04, Uncertain significance, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ce
- G59D (p.Gly59Asp), cosmic curated COSV99029, gnomAD rs1456999060, REVEL 0.12, CADD 0.06
- G59S (p.Gly59Ser), gnomAD 17-44349462-G-A, REVEL 0.04, CADD 0.87
- G59G (p.Gly59Gly), gnomAD 17-44349464-C-A, CADD 0.33
- P60R (p.Pro60Arg), ExAC rs777882796, gnomAD rs777882796, REVEL 0.28, CADD 14.00
- P60S (p.Pro60Ser), Ensembl rs1598362779
- P60L (p.Pro60Leu), gnomAD 17-44349466-C-T, REVEL 0.08, CADD 6.03
- C61G (p.Cys61Gly), gnomAD rs1291370551, REVEL 0.56, CADD 24.20
- C61Y (p.Cys61Tyr), rs2510054490, ClinGen CA399759719, ClinVar RCV003008312, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- Q62H (p.Gln62His), gnomAD rs2048350899, REVEL 0.23, CADD 15.80, Likely benign
- Q62Q (p.Gln62Gln), rs2048350899, gnomAD 17-44349473-G-A, CADD 6.18
- V63F (p.Val63Phe), ExAC rs746868852, gnomAD rs746868852
- V63I (p.Val63Ile), ExAC rs746868852, gnomAD rs746868852
- V63A (p.Val63Ala), gnomAD 17-44349475-T-C, REVEL 0.12, CADD 0.01
- D64N (p.Asp64Asn), rs1567885586, ClinGen CA399759759, ClinVar RCV002587408, Ensembl rs1567885586, REVEL 0.04, CADD 8.17, Uncertain significance, Neuronal ceroid lipofuscinosis 11; GRN-related frontotemporal lobar degeneration
- A65G (p.Ala65Gly), NCI-TCGA Cosmic COSV9927, Variant assessed as somatic; moderate impact.
Public GRN analysis runs
- GRN analysis run — GRN (1,037 variants) — completed 2026-08-21